Medicines, 2024
Shortlist up to four to read them side by side.
657 medicine recalls FDA’s Enforcement Report published in 2024, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
657of 657 medicine recallsshown with your filters
The list
- Medicine recall Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day Failed Impurities/Degradation Specifications. Class IIIFDA’s classJun 12, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 12, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day Failed Impurities/Degradation Specifications. Class IIIFDA’s classJun 12, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 12, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle… Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet… Class IIIFDA’s classJun 12, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 12, 2024ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Cathflo activase (ALTEPLASE), 2mg vials Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Zoledronic Acid Injection 5mg/100mL Sterile Solution, 100mL Single-Dose vials Lack of Assurance of Sterility: Leaking vials Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate FDA Class I, its most serious class Class IFDA’s class (needs attention)Jun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular… Lack of Assurance of Sterility Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dexamethasone-Moxifloxacin Lack of Assurance of Sterility Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dexamethasone-Moxifloxacin- Ketorolac Lack of Assurance of Sterility Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection Lack of Assurance of Sterility Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection Lack of Assurance of Sterility Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle Presence of Foreign Substance: metal in tablet Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Cefdinir for Oral Suspension USP, 250 mg/5 mL Defective container: lack of seal integrity. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular… Lack of Assurance of Sterility Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%) Enriched with Capsaicin, Aloe Vera,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Bull Frog SPF 50 Amphibious Lotion SPF 50 Amphibious Lotion with Water Armor Tech, Broad Spectrum Sunscreen… Out of Specification for active ingredient Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%), Original… Out of Specification for active ingredient Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Pump Capsaicin, Aloe Vera,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera,… Out of Specification for active ingredient. Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%), SPF 40+, Broad… Out of Specification for active ingredient Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg Lack of Assurance of Sterility: Complaints of syringe breakage Class IIFDA’s classJun 5, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 5, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle Failed Release Testing: Out of specification for particulate matter test. Class IIIFDA’s classMay 29, 2024in FDA’s Enforcement Report2 statesnamed in where it went PublishedMay 29, 2024ClassClass IIIStatusOngoingWherePennsylvania and Texas
- Medicine recall niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL Lack of Assurance of Sterility. Class IIFDA’s classMay 29, 2024in FDA’s Enforcement ReportUtahthe one state its words name PublishedMay 29, 2024ClassClass IIStatusTerminatedWhereUtah
- Medicine recall Sirolimus Tablets 1mg Tablets 100-count bottle Failed Impurities/Degradation Specifications Class IIIFDA’s classMay 29, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 29, 2024ClassClass IIIStatusOngoingWhereNationwide
- Medicine recall Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Class IIFDA’s classMay 29, 2024in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 29, 2024ClassClass IIStatusOngoingWhereCalifornia, Connecticut, Florida, Kansas and Oklahoma
- Medicine recall Haloperidol decanoate Injection 50mg/mL Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI). Class IIFDA’s classMay 29, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 29, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Vasopressin Injection, USP, 200 Units per 10 mL Subpotent product in addition to having out-of-specification results for impurities. Class IIFDA’s classMay 29, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 29, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Phenylephrine Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine. FDA Class I, its most serious class Class IFDA’s class (needs attention)May 29, 2024in FDA’s Enforcement Report5 statesnamed in where it went PublishedMay 29, 2024ClassClass IStatusCompletedWhereColorado, Georgia, Pennsylvania, South Dakota and Washington
- Medicine recall Schwinnng Herbal Dietary Supplement Capsules Marketed Without An Approved NDA/ANDA FDA Class I, its most serious class Class IFDA’s class (needs attention)May 22, 2024in FDA’s Enforcement ReportNot namedno state, in where it went PublishedMay 22, 2024ClassClass IStatusTerminatedWhereNo state named
- Medicine recall Gordofilm Wart Remover (salicylic acid 16.7% USP) cGMP Deviations Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusCompletedWhereNationwide
- Medicine recall Cefdinir for Oral Suspension USP 250 mg/5 mL Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Cefdinir for Oral Suspension USP 125 mg/5 mL Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle Presence of foreign substance: plastic-like substance. Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL Presence of Particulate Matter: Potential for black particulates in the drug product. Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Cherry Flavor, 10 fl Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Meijer Magnesium Citrate Saline Laxative Oral Solution Dye Free, Sugar Free Grape, 10 fl Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria Class IIFDA’s classMay 22, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 22, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Duloxetine Delayed-Release Capsules, USP, 30mg CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Class IIFDA’s classMay 15, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 15, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Duloxetine Delayed-Release Capsules, USP, 20 mg, , 500-count bottles CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Class IIFDA’s classMay 15, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 15, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Duloxetine Delayed-Release Capsules, USP, 60 mg, 90-count bottles CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit Class IIFDA’s classMay 15, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 15, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Javygtor (sapropterin dihydrochloride) Powder for Oral Solution 100mg, 30 individual packets per carton Sub-potent Drug; powder discoloration associated with decreased potency FDA Class I, its most serious class Class IFDA’s class (needs attention)May 15, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 15, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall Sapropterin Dihydrochloride Powder for Oral Solution 100mg, 30 individual packets per carton Sub-potent Drug; powder discoloration associated with decreased potency FDA Class I, its most serious class Class IFDA’s class (needs attention)May 15, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 15, 2024ClassClass IStatusOngoingWhereNationwide
- Medicine recall traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol Class IIFDA’s classMay 15, 2024in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedMay 15, 2024ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Timolol Maleate Ophthalmic Solution, USP, 0.5% Defective Container: yellow-colored spike from cap lodged in the nozzle. Class IIFDA’s classMay 15, 2024in FDA’s Enforcement ReportNew Jerseythe one state its words name PublishedMay 15, 2024ClassClass IIStatusTerminatedWhereNew Jersey
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.